Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler A Kokjohn

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
American Journal of Neurodegenerative Disease|October 12, 2016
Chemical and neuropathological analyses of an Alzheimer's disease patient treated with solanezumabAlex E Roher, Chera L Maarouf, Tyler A Kokjohn, et al.
Journal of Alzheimer'S Disease : JAD|January 26, 2011
Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipientAlex E Roher, Chera L Maarouf, Ian D Daugs, et al.
Current Alzheimer Research|August 20, 2009
Proteomic analysis of Alzheimer's disease cerebrospinal fluid from neuropathologically diagnosed subjectsChera L Maarouf, Tracy M Andacht, Tyler A Kokjohn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 27, 2003
Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's diseaseAlex E Roher, Chera Esh, Tyler A Kokjohn, et al.
Neurochemistry International|August 17, 2017
APP/Aβ structural diversity and Alzheimer's disease pathogenesisAlex E Roher, Tyler A Kokjohn, Steven G Clarke, et al.
Neurological Research|August 15, 2012
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjectsChera L Maarouf, Thomas G Beach, Charles H Adler, et al.
Plos One|May 23, 2012
Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's diseaseJesse M Hunter, Jason Kwan, Michael Malek-Ahmadi, et al.
Biochemistry Insights|September 12, 2014
Molecular Differences and Similarities Between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of AmyloidosisChera L Maarouf, Tyler A Kokjohn, Charisse M Whiteside, et al.
Neurochemistry International|December 13, 2012
Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterationsEduardo M Castaño, Chera L Maarouf, Terence Wu, et al.
Neurological Research|September 2, 2006
Interaction of cardiovascular disease and neurodegeneration: transcranial Doppler ultrasonography and Alzheimer's diseaseAlex E Roher, Zsolt Garami, Andrei V Alexandrov, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
American Journal of Neurodegenerative Disease|October 12, 2016
Chemical and neuropathological analyses of an Alzheimer's disease patient treated with solanezumabAlex E Roher, Chera L Maarouf, Tyler A Kokjohn, et al.
Journal of Alzheimer'S Disease : JAD|January 26, 2011
Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipientAlex E Roher, Chera L Maarouf, Ian D Daugs, et al.
Current Alzheimer Research|August 20, 2009
Proteomic analysis of Alzheimer's disease cerebrospinal fluid from neuropathologically diagnosed subjectsChera L Maarouf, Tracy M Andacht, Tyler A Kokjohn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 27, 2003
Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's diseaseAlex E Roher, Chera Esh, Tyler A Kokjohn, et al.
Neurochemistry International|August 17, 2017
APP/Aβ structural diversity and Alzheimer's disease pathogenesisAlex E Roher, Tyler A Kokjohn, Steven G Clarke, et al.
Neurological Research|August 15, 2012
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjectsChera L Maarouf, Thomas G Beach, Charles H Adler, et al.
Plos One|May 23, 2012
Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's diseaseJesse M Hunter, Jason Kwan, Michael Malek-Ahmadi, et al.
Biochemistry Insights|September 12, 2014
Molecular Differences and Similarities Between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of AmyloidosisChera L Maarouf, Tyler A Kokjohn, Charisse M Whiteside, et al.
Neurochemistry International|December 13, 2012
Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterationsEduardo M Castaño, Chera L Maarouf, Terence Wu, et al.
Neurological Research|September 2, 2006
Interaction of cardiovascular disease and neurodegeneration: transcranial Doppler ultrasonography and Alzheimer's diseaseAlex E Roher, Zsolt Garami, Andrei V Alexandrov, et al.
Pageof 5